Assessment of a Medication Reconciliation Program on Transitional Care
Impact of a Medication Reconciliation Program on Patients Transitioning From an Inpatient Hospitalization to Primary Care
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of this study is to assess and compare the effectiveness of the Kaiser Permanente Colorado's (KPCO) Call Center's Medication Reconciliation Program and standard care in regards to their impacts on emergency department (ED) and urgent care visits, inpatient rehospitalizations, and adherence to preferred, formulary medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2005
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2007
CompletedFirst Submitted
Initial submission to the registry
April 16, 2007
CompletedFirst Posted
Study publicly available on registry
April 18, 2007
CompletedApril 18, 2007
April 1, 2007
April 16, 2007
April 16, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Number of emergency room visits post-discharge
Number of urgent care visits post-discharge
Number of inpatient rehospitalizations
Adherence to preferred, formulary medications
Interventions
Eligibility Criteria
You may qualify if:
- \- KPCO members discharged on medications from either the Good Samaritan or St. Joseph hospitals
You may not qualify if:
- \- Discharged from the IP to a hospice or long term care or skilled nursing facility, less than 18 years of age, discharged from a hospital other than Good Samaritan or St. Joseph, or enrolled in another trial that is identified in Health Connect EMR
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaiser-Permanente Colorado Region, Clinical Pharmacy Dept.
Aurora, Colorado, 80011, United States
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas M Delate, PhD
Kaiser-Permanente Colorado Region, Clinical Pharmacy Department
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 16, 2007
First Posted
April 18, 2007
Study Start
June 1, 2005
Study Completion
March 1, 2007
Last Updated
April 18, 2007
Record last verified: 2007-04